In contrast, Myostatin serum levels were comparable between patients on regular hemodialysis (Figure 2E) and patients with or without diabetes mellitus (Figure 2F), while patients with liver cirrhosis showed a trend towards higher Myostatin levels compared to non-cirrhotic patients (p = 0.081, Figure 2G). The gene discussed is MSTN; the disease is diabetes mellitus.